Sutherland Everett Rand Insider Trading Activity (UPB)

Summary

Updated Jul 16, 2026

Sutherland Everett Rand has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $32K.

Profile

Everett Rand Sutherland is the Chief Executive Officer of Upstream Bio, Inc., a clinical-stage biotechnology company focused on inflammatory diseases and the development of verekitug, a TSLP receptor antagonist in clinical development. The SEC filing dated 2026-01-06 lists him as CEO with no reported purchases or sales, underscoring his role as the primary executive leader of the company. He leads Upstream Bio's strategic direction and clinical development efforts.

Role	Insider
Notability	40/100

Board memberships

Upstream Bio, Inc.

Awards & honors

Appointed Chief Executive Officer of Upstream Bio, Inc.
Oversees development of verekitug, a TSLP receptor antagonist in clinical development
Leads the company's strategic direction for inflammatory disease programs

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-06-17	UPB	Upstream Bio, Inc.	S — Open-market sale	2.1K	$6.10	$13K
2026-03-17	UPB	Upstream Bio, Inc.	S — Open-market sale	2.1K	$9.29	$19K
2026-01-06	UPB	Upstream Bio, Inc.	A — Grant or award	75.0K	$0.00

Frequently Asked Questions

Who is Sutherland Everett Rand?

How many SEC Form 4 filings has Sutherland Everett Rand submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Sutherland Everett Rand been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 2 open-market sales ($32K) across all tracked filings.

Where can I see all of Sutherland Everett Rand's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Sutherland Everett Rand — SEC Form 4 Insider Trading Activity